Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

Safety of combined drug use in patients with cardiovascular and cerebrovascular diseases: an analysis based on the spontaneous reporting database of adverse drug reactions in Hubei Province

ObjectiveThere is a lack of studies investigating the safety of combination regimens specifically for cardiovascular and cerebrovascular diseases. This study aimed to evaluate the safety of combination drugs for cardiovascular and cerebrovascular diseases using real-world data.MethodsWe analyzed adv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jia Wang, Yuhang Zhao, Zherui Chen, Rui Huang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	cardiovascular diseases cerebrovascular diseases adverse drug reaction association rule Ω shrinkage measurement
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1451713/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Risk factors for severe adverse drug reactions in hospitalized patients
by: Petrović Nemanja Z., et al.
Published: (2025-01-01)

Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-01-01)

Corrigendum: Adverse drug events (ADEs) risk signal mining related to eculizumab based on the FARES database
by: Xi-Feng Wang, et al.
Published: (2025-02-01)

Precision Adverse Drug Reactions Prediction with Heterogeneous Graph Neural Network
by: Yang Gao, et al.
Published: (2025-01-01)

Adverse drug reactions in the ambulatory internal patients at the emergency department: Focus on causality assessment and drug-drug interactions
by: Verbič Matej Dobravc, et al.
Published: (2023-06-01)

Incidence of adverse drug reactions among tuberculosis patients initiated on daily drug regimen in a southern district of Karnataka
by: R. N. Hithaish Kumar, et al.
Published: (2025-01-01)

A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India
by: Sujata Sinha, et al.
Published: (2024-01-01)

Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A Retrospective Pharmacovigilance Study
by: Alshareef H, et al.
Published: (2025-02-01)

Pharmacotherapy, adverse drug reactions, and factors associated with clinical outcome in primary open-angle glaucoma
by: Anushree Dayanand, et al.
Published: (2025-01-01)

Risk Factors Analysis of Cutaneous Adverse Drug Reactions Caused by Targeted Therapy and Immunotherapy Drugs for Oncology and Establishment of a Prediction Model
by: Zimin Zhang, et al.
Published: (2025-01-01)

Leflunomide induced drug reaction with eosinophilia and systemic symptoms: A lesser known entity
by: Deepak Vashisht, et al.
Published: (2020-01-01)

Predicting risk on cardiovascular or cerebrovascular disease based on a physical activity cohort: Results from APAC study
by: Juan Zhao, et al.
Published: (2023-04-01)

Knowledge, Attitude, Practice, and Barriers of Adverse Drug Reaction Reporting Among Healthcare Professionals in Timor‐Leste: A Cross‐Sectional Survey
by: Juanina daCosta, et al.
Published: (2025-01-01)

Drug-induced urinary retention: a real-world pharmacovigilance study using FDA and Canada vigilance databases
by: Xianyu Dai, et al.
Published: (2025-01-01)

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS
by: Lin Li
Published: (2025-01-01)

Real-world evaluation of select adverse drug reactions and healthcare utilization associated with parenteral Ibuprofen and ketorolac in adult and pediatric patients
by: Mosadoluwa Afolabi, et al.
Published: (2025-01-01)

Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system
by: Ashwin Kamath
Published: (2025-01-01)

DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system
by: Xia Zhang, et al.
Published: (2025-01-01)

Assessment of stress hyperglycemia ratio to predict all-cause mortality in patients with critical cerebrovascular disease: a retrospective cohort study from the MIMIC-IV database
by: Yuwen Chen, et al.
Published: (2025-02-01)

Relationship between Periodontitis and Ischemic Cerebrovascular Disease
by: Magda Pinilla Pérez, et al.
Published: (2024-03-01)

Adverse Reactions from Topical Ophthalmic Anesthetic Abuse
by: Ali Sharifi, et al.
Published: (2022-11-01)

Association between CYP2C19 polymorphism and proton pump inhibitors adverse drug reactions: a narrative review
by: Asmaa Ibrahim, et al.
Published: (2025-02-01)

Early-life famine exposure may modify the association between long-term temperature variability and cardio-cerebrovascular diseases: a nationwide study
by: Yao Wu, et al.
Published: (2025-01-01)

Analysis of the effectiveness of premedication in preventing early adverse reactions to antivenom serum from 2017 to 2021: A cohort study
by: Gustavo Abud Priedols, et al.
Published: (2025-01-01)

Clinic Practical Guides for Cerebrovascular Diseases
by: Miguel Angel Buergo Zuaznábar, et al.
Published: (2007-05-01)

Characteristics and contributing factors of adverse drug reactions: an analytical study of patients with tuberculosis receiving treatment under the National TB Program of India [version 2; peer review: 1 approved, 2 approved with reservations, 1 not approved]
by: Jay Patel, et al.
Published: (2024-07-01)

Correlation of PM2.5 pollution and daily mortality rate of cardiovascular and cerebrovascular diseases in Northeast China through PM2.5 sources analysis
by: Hong Qianqi, et al.
Published: (2025-01-01)

Data mining and analysis of adverse events of Vedolizumab based on the FAERS database
by: Qinyun Xu, et al.
Published: (2025-01-01)

Complications and Mortality Characterization in Acute Ischemic Cerebrovascular Disease
by: Ricardo Leyva Tornés, et al.
Published: (2021-09-01)

Association between exposure to 35 environmental pollutants and mortality from cerebrovascular diseases: A long-term prospective study
by: Lingjun Yan, et al.
Published: (2025-02-01)

Extracranial carotid plaque calcification and its association with risk factors for cerebrovascular events: insights from the ANTIQUE study
by: David Pakizer, et al.
Published: (2025-01-01)

Compensatory increase in oxygen extraction fraction is associated with age-related cerebrovascular disease
by: John McFadden, et al.
Published: (2025-01-01)

Rare skin adverse reactions induced by osimertinib: a case report and literature review
by: Ye Zhang, et al.
Published: (2025-01-01)

The Cerebrovascular Disease and Nutritional State.
by: Leticia del Rosario Cruz, et al.
Published: (2007-05-01)

Analysis of ADR reports of cetuximab based on the FDA adverse event reporting system database
by: Shuai Zhao, et al.
Published: (2025-02-01)

The efficacy and safety of indobufen in patients with ischemic cardiovascular or cerebrovascular diseases: systematic review and meta-analysis
by: Xiaolu Luo, et al.
Published: (2025-01-01)

Secondary Trigeminal Neuralgia after a Brainstem Hemorrhagic Stroke with Adverse Reaction to Carbamazepine: A Case Report
by: I Gusti Agung Ayu Andra Yusari, et al.
Published: (2024-12-01)

Cardiovascular Reactivity to Mental Stress and Adverse Cardiovascular Outcomes in Patients With Coronary Artery Disease
by: Kasra Moazzami, et al.
Published: (2025-02-01)

Cardiovascular Drug Therapy /
by: Messerli, Franz H.
Published: (1990)

Cerebrovascular illness in the province of Cienfuegos. Tendency lines. A six years study
by: Rubén Bembibre Taboada, et al.
Published: (2006-08-01)